Fingerprint
Dive into the research topics of 'Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study
The European FK 506 Multicentre Psoriasis Study Group: Clinical Centers and Principal Investigators, A. Y. Rubins (Member of the Working Group), I. Hartmane (Member of the Working Group)
Research output: Contribution to journal › Article › peer-review
175
Citations
(Scopus)